Akslen LA - Search Results

1

Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma.

Wik E, Ræder MB, Krakstad C, Trovik J, Birkeland E, Hoivik EA, Mjos S, Werner HM, Mannelqvist M, Stefansson IM, Oyan AM, Kalland KH, Akslen LA, Salvesen HB. Wik E, et al. Among authors: akslen la. Clin Cancer Res. 2013 Mar 1;19(5):1094-105. doi: 10.1158/1078-0432.CCR-12-3039. Epub 2013 Jan 14. Clin Cancer Res. 2013. PMID: 23319822

2

Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system.

Salvesen H, Njølstad PR, Akslen LA, Albrektsen G, Søreide O, Varhaug JE. Salvesen H, et al. Among authors: akslen la. Eur J Surg. 1992 Nov-Dec;158(11-12):583-9. Eur J Surg. 1992. PMID: 1363062

3

Prognostic importance of various clinicopathological features in papillary thyroid carcinoma.

Akslen LA, Myking AO, Salvesen H, Varhaug JE. Akslen LA, et al. Eur J Cancer. 1992;29A(1):44-51. doi: 10.1016/0959-8049(93)90574-y. Eur J Cancer. 1992. PMID: 1445745

4

Thyroid carcinoma: results from surgical treatment in 211 consecutive patients.

Salvesen H, Njølstad PR, Akslen LA, Albrektsen G, Viste A, Søreide O, Varhaug JE. Salvesen H, et al. Among authors: akslen la. Eur J Surg. 1991 Sep;157(9):521-6. Eur J Surg. 1991. PMID: 1683575

5

Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas.

Haugen DR, Akslen LA, Varhaug JE, Lillehaug JR. Haugen DR, et al. Among authors: akslen la. Int J Cancer. 1993 Aug 19;55(1):37-43. doi: 10.1002/ijc.2910550108. Int J Cancer. 1993. PMID: 8102129

6

Prognostic impact of EGF-receptor in papillary thyroid carcinoma.

Akslen LA, Myking AO, Salvesen H, Varhaug JE. Akslen LA, et al. Br J Cancer. 1993 Oct;68(4):808-12. doi: 10.1038/bjc.1993.432. Br J Cancer. 1993. PMID: 8398712 Free PMC article.

7

Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.

Akslen LA, Varhaug JE. Akslen LA, et al. Cancer. 1995 Nov 1;76(9):1643-54. doi: 10.1002/1097-0142(19951101)76:9<1643::aid-cncr2820760922>3.0.co;2-#. Cancer. 1995. PMID: 8635070

8

Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas.

Haugen DR, Akslen LA, Varhaug JE, Lillehaug JR. Haugen DR, et al. Among authors: akslen la. Cancer Res. 1996 Mar 15;56(6):1184-8. Cancer Res. 1996. PMID: 8640794

9

Recurrence of endometrial carcinoma and the value of routine follow up.

Salvesen HB, Akslen LA, Iversen T, Iversen OE. Salvesen HB, et al. Among authors: akslen la. Br J Obstet Gynaecol. 1997 Nov;104(11):1302-7. doi: 10.1111/j.1471-0528.1997.tb10979.x. Br J Obstet Gynaecol. 1997. PMID: 9386033

10

Poorer survival of nulliparous women with endometrial carcinoma.

Salvesen HB, Akslen LA, Albrektsen G, Iversen OE. Salvesen HB, et al. Among authors: akslen la. Cancer. 1998 Apr 1;82(7):1328-33. doi: 10.1002/(sici)1097-0142(19980401)82:7<1328::aid-cncr16>3.0.co;2-8. Cancer. 1998. PMID: 9529025

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

370 results

Search Page